Nanoscope Technologies LLC
Bedford, TX
- UEI
- H6DNZXT5MMT1
- CAGE
- 5KA02
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 1312 Brown Trail Ste A, Bedford, TX 76022, USA
- Website
- nanoscopetech.com
- Founded
- 2009
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Sonogenetic restoration of vision for retinitis pigmentosa - retinitis pigmentosa (RP) often results in legal… | National Eye Institute | $3,142,735 | |
| Mechanosensitive channel based pressure-modulating gene therapy for glaucoma treatment - glaucoma is recalcitrant to… | National Eye Institute | $2,309,108 | |
| Targeted nano-enhanced optical delivery of opsin for dry-AMD therapy | National Eye Institute | $4,128,187 | |
| Bioluminescent multi-characteristic opsin for simultaneous optical stimulation and large-scale monitoring of the… | National Eye Institute | $3,109,835 | |
| Broad-band opsin and targeted optical-delivery for retinitis pigmentosa treatment | National Eye Institute | $1,683,150 |
About Nanoscope Technologies LLC
Nanoscope Technologies LLC is a for-profit limited liability company that specializes in developing innovative therapies for vision restoration and eye disease treatment. Registered to receive federal awards since July 2, 2009, the company focuses on cutting-edge research in ophthalmology, particularly in the areas of gene therapy and sonogenetic stimulation. Nanoscope Technologies has secured multiple federal grant awards from the National Eye Institute (NEI) to advance its groundbreaking work in addressing retinal degenerative diseases and glaucoma.
The company's federal grant portfolio includes several significant projects aimed at revolutionizing treatments for eye disorders. One major initiative involves the development of a non-invasive "sonogenetic" therapy to restore vision in patients with retinitis pigmentosa, supported by a $785,380 Cooperative Agreement grant under the NEI's Vision Research program. This project utilizes ultrasound stimulation of engineered mechanosensitive channels in retinal ganglion cells to achieve vision restoration in animal models. Another key project focuses on creating a pressure-modulating gene therapy for glaucoma treatment, using engineered mechanosensitive channels to improve aqueous humor drainage in the eye. Additionally, Nanoscope Technologies is working on targeted nano-enhanced optical delivery of opsin for dry age-related macular degeneration (AMD) therapy. These grants, all awarded by the National Eye Institute, demonstrate the company's commitment to developing innovative, long-lasting treatments for various eye conditions that could significantly improve the lives of millions of Americans affected by vision loss and eye diseases.
Quick answers
What is Nanoscope Technologies LLC's UEI?
Nanoscope Technologies LLC's Unique Entity ID (UEI) in SAM.gov is H6DNZXT5MMT1.
What is Nanoscope Technologies LLC's CAGE code?
Nanoscope Technologies LLC's CAGE code is 5KA02.
What is Nanoscope Technologies LLC's primary NAICS code?
Nanoscope Technologies LLC's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Nanoscope Technologies LLC located?
Nanoscope Technologies LLC's physical address in SAM.gov is 1312 Brown Trail Ste A, Bedford, TX 76022, USA.
Is Nanoscope Technologies LLC registered in SAM.gov?
Yes. Nanoscope Technologies LLC's SAM.gov registration is active through November 12, 2026.
What is Nanoscope Technologies LLC's most recent federal award?
Nanoscope Technologies LLC's most recent federal grant award is Sonogenetic restoration of vision for retinitis pigmentosa - retinitis pigmentosa (RP) often results in legal… (U01EY035026), from National Eye Institute, on May 1, 2024.
On GovTribe
See Nanoscope Technologies LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors